Shopping Cart
- Remove All
Your shopping cart is currently empty
SSR504734 is an orally active, selective, and reversible inhibitor of human, rat, and mouse GlyT1 (IC50 = 18, 15, and 38 nM, respectively). SSR504734 exhibits activity in schizophrenia, anxiety, and depression models [1].

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $68 | In Stock | |
| 5 mg | $163 | In Stock | |
| 10 mg | $263 | In Stock | |
| 25 mg | $476 | In Stock | |
| 50 mg | $715 | In Stock | |
| 100 mg | $987 | In Stock |
| Description | SSR504734 is an orally active, selective, and reversible inhibitor of human, rat, and mouse GlyT1 (IC50 = 18, 15, and 38 nM, respectively). SSR504734 exhibits activity in schizophrenia, anxiety, and depression models [1]. |
| Targets&IC50 | GlyT1 (human):18 nM, GlyT1 (rat):15 nM |
| In vitro | SSR504734 (15 nM-86 μM; 10 min) inhibits the ex vivo uptake of glycine in human SK-N-MC and rat C6 cells, with IC50 values of 18 nM and 15 nM, respectively [1]. |
| In vivo | SSR504734 (i.p. and p.o.; 1-100 mg/kg; once) demonstrates good oral bioavailability with ID50 values of 5.0 and 4.6 mg/kg for i.p. and p.o. treatments, respectively [1]. At 30 mg/kg (i.p.; once), it maintains approximately 80% inhibition of specific glycine uptake from 1 to 7 hours post-administration [1]. At 10 mg/kg (i.p.; once), it rapidly and significantly increases extracellular glycine levels in the prefrontal cortex of freely moving male Sprague-Dawley rats [1]. |
| Molecular Weight | 433.30 |
| Formula | C20H21Cl2F3N2O |
| Cas No. | 615571-23-8 |
| Smiles | Cl.[H][C@]1(CCCCN1)[C@@H](NC(=O)c1cccc(c1Cl)C(F)(F)F)c1ccccc1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.